Article
LncRNA TP73-AS1 Exacerbates the Non-Small-Cell Lung Cancer (NSCLC) Process via Regulating…
Evidence-Based Complementary and Alternative Medicine · 2022 · Yueyang Tong, author Zhemin Feng, author Yaqian Li, author Chenxi Yan, author Wenbo He, author Xueyuan Chen, author Chen-Huan Yu, Academic Editor
Key facts
| Title | LncRNA TP73-AS1 Exacerbates the Non-Small-Cell Lung Cancer (NSCLC) Process via Regulating miR-125a-3p-Mediated ACTN4 |
|---|---|
| First author | Yueyang Tong, author Zhemin Feng, author Yaqian Li, author Chenxi Yan, author Wenbo He, author Xueyuan Chen, author Chen-Huan Yu, Academic Editor |
| Journal | Evidence-Based Complementary and Alternative Medicine |
| Published | Jun 2, 2022 |
| DOI | 10.1155/2022/4098271 |
| Product codes mentioned | GIA |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1